Episode 27 – Using Artificial Intelligence to speed Alzheimer’s studies Saving Minds
-
- 健康與體能
This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.
This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research.
24 分鐘